6 unknown. 6 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
| Phase 1 | 3 | Unknown 3 |
| Phase 3 | 1 | Unknown 1 |
Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CelAgace™ OraRinse Solution for Treatment of Candidiasis silver citrate complex and acemannan - Candidiasis, Oral | Phase 1 / Phase 2 | Unknown | CelaCare Technologies, Inc. | 15 | 2024-09-01 | 2024-02-09 |
| Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection BGY-1601-VT, PLACEBO - Bacterial Vaginosis, Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | NEXBIOME THERAPEUTICS | 165 | 2024-07-08 | 2024-06-12 |
| A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis Chlorhexidine Gluconate, Fluconazole - Candidiasis, Vulvovaginal | Phase 2 | Unknown | Karolinska Institutet | 60 | 2022-04-27 | 2022-05-20 |
| Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis Amphotericin B cholesteryl sulfate complex for injection(ABCD) - Invasive Candidiasis, Invasive Aspergillosis | Phase 2 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 60 | 2020-01-01 | 2020-01-13 |
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis | Phase 2 / Phase 3 | Unknown | ProFem GmbH | 432 | 2019-10-01 | 2022-09-22 |
| Patients With Vulvovaginal Candidiasis EPP-AF Gel 1%, EPP-AF Gel 2%, Clotrimazole - Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | University of Sao Paulo | 90 | 2018-01-30 | 2018-10-19 |
Candidiasis, Vulvovaginal (4) · Candidiasis, Invasive (1) · Candidiasis, Oral (1) · Vaginitis (1) · Vaginosis, Bacterial (1) · Vulvovaginitis (1)
Bacterial Infections and Mycoses (6) · Infections (6) · Mycoses (6) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Urogenital Diseases (4) · Vaginal Diseases (4) · Vulvar Diseases (4) · Vulvitis (4) · Vaginitis (3) · Vulvovaginitis (3) · Bacterial Infections (1)
Fluconazole (2) · Amphotericin B (1) · Clotrimazole (1) · acemannan (1) · chlorhexidine gluconate (1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · CelaCare Technologies, Inc. (1) · Karolinska Institutet (1) · NEXBIOME THERAPEUTICS (1) · ProFem GmbH (1) · University of Sao Paulo (1)
Austria (1) · Brazil (1) · Poland (1) · Slovakia (1) · Sweden (1) · United States (1)
Cathrin Alvendal, MD, PhD (1) · Herbert Kiss, Prof. (1) · Jacqueline M. Plemons, DDS, MS (1)